BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 29502462)

  • 1. Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.
    Esteve-Solé A; Sologuren I; Martínez-Saavedra MT; Deyà-Martínez À; Oleaga-Quintas C; Martinez-Barricarte R; Martin-Nalda A; Juan M; Casanova JL; Rodriguez-Gallego C; Alsina L; Bustamante J
    Crit Rev Clin Lab Sci; 2018 May; 55(3):184-204. PubMed ID: 29502462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical and Genetic Features of 32 Iranian Patients.
    Mahdaviani SA; Mansouri D; Jamee M; Zaki-Dizaji M; Aghdam KR; Mortaz E; Khorasanizadeh M; Eskian M; Movahedi M; Ghaffaripour H; Baghaie N; Hassanzad M; Chavoshzadeh Z; Mansouri M; Mesdaghi M; Ghaini M; Noori F; Eskandarzadeh S; Kahkooi S; Poorabdolah M; Tabarsi P; Moniri A; Farnia P; Karimi A; Boisson-Dupuis S; Rezaei N; Marjani M; Casanova JL; Bustamante J; Velayati AA
    J Clin Immunol; 2020 Aug; 40(6):872-882. PubMed ID: 32602053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular, Immunological, and Clinical Features of 16 Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease.
    Sarrafzadeh SA; Nourizadeh M; Mahloojirad M; Fazlollahi MR; Shokouhi Shoormasti R; Badalzadeh M; Deswarte C; Casanova JL; Pourpak Z; Bustamante J; Moin M
    J Clin Immunol; 2019 Apr; 39(3):287-297. PubMed ID: 30715640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Molecular Findings in Mendelian Susceptibility to Mycobacterial Diseases: Experience From India.
    Taur PD; Gowri V; Pandrowala AA; Iyengar VV; Chougule A; Golwala Z; Chandak S; Agarwal R; Keni P; Dighe N; Bodhanwala M; Prabhu S; George B; Fouzia NA; Edison ES; Arunachalam AK; Madkaikar MR; Dalvi AD; Yadav RM; Bargir UA; Kambli PM; Rawat A; Das J; Joshi V; Pilania RK; Jindal AK; Bhat S; Bhattad S; Unni J; Radhakrishnan N; Raj R; Uppuluri R; Patel S; Lashkari HP; Aggarwal A; Kalra M; Udwadia Z; Bafna VS; Kanade T; Puel A; Bustamante J; Casanova JL; Desai MM
    Front Immunol; 2021; 12():631298. PubMed ID: 33732252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNγ immunity.
    Dolezalova K; Strachan T; Matej R; Ricna D; Bloomfield M
    Eur J Dermatol; 2022 Sep; 32(4):495-504. PubMed ID: 36069176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity.
    Bustamante J; Boisson-Dupuis S; Abel L; Casanova JL
    Semin Immunol; 2014 Dec; 26(6):454-70. PubMed ID: 25453225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three novel compound heterozygous IL12RB1 mutations in Chinese patients with Mendelian susceptibility to mycobacterial disease.
    Zhou X; Jia W; Ni Z; Wang A; Liu Z; Hou M; Zhou M; Tang Z; Zhang D; Li L; Han T; Tan Y; Luo G; Wang J; Wu Y; Zhang X
    PLoS One; 2019; 14(4):e0215648. PubMed ID: 30998751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of interleukin-12 receptor β1 and interferon gamma receptor 1 deficiency in patients with disseminated BCG infection.
    Pourakbari B; Hosseinpour Sadeghi R; Mahmoudi S; Parvaneh N; Keshavarz Valian S; Mamishi S
    Allergol Immunopathol (Madr); 2019; 47(1):38-42. PubMed ID: 30268380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mendelian susceptibility to mycobacterial diseases: state of the art.
    Noma K; Mizoguchi Y; Tsumura M; Okada S
    Clin Microbiol Infect; 2022 Nov; 28(11):1429-1434. PubMed ID: 35283318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mendelian susceptibility to mycobacterial disease: recent discoveries.
    Bustamante J
    Hum Genet; 2020 Jun; 139(6-7):993-1000. PubMed ID: 32025907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mendelian Susceptibility to Mycobacterial Disease: Retrospective Clinical and Genetic Study in Mexico.
    Peñafiel Vicuña AK; Yamazaki Nakashimada M; León Lara X; Mendieta Flores E; Nuñez Núñez ME; Lona-Reyes JC; Hernández Nieto L; Ramírez Vázquez MG; Barroso Santos J; López Iñiguez Á; González Y; Torres M; Lezana Fernández JL; Román Montes CM; Medina-Torres EA; González Serrano E; Bustamante Ogando JC; Lugo Reyes S; Zavaleta Martínez O; Staines Boone AT; Venegas Montoya E; Aguilar Gómez NE; Soudeé C; Jouanguy E; Puel A; Boisson-Dupuis S; Pedraza Sánchez S; Casanova JL; Espinosa Rosales F; Espinosa Padilla S; Bustamante J; Blancas Galicia L
    J Clin Immunol; 2023 Jan; 43(1):123-135. PubMed ID: 36044171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs).
    Lee WI; Huang JL; Yeh KW; Jaing TH; Lin TY; Huang YC; Chiu CH
    J Formos Med Assoc; 2011 Dec; 110(12):750-8. PubMed ID: 22248828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds.
    Errami A; Baghdadi JE; Ailal F; Benhsaien I; Bakkouri JE; Jeddane L; Rada N; Benajiba N; Mokhantar K; Ouazahrou K; Zaidi S; Abel L; Casanova JL; Boisson-Dupuis S; Bustamante J; Bousfiha AA
    J Clin Immunol; 2023 May; 43(4):728-740. PubMed ID: 36630059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and immune functional profiling of patients with suspected Mendelian Susceptibility to Mycobacterial Disease in South Africa.
    van Coller A; Glanzmann B; Cornelissen H; Möller M; Kinnear C; Esser M; Glashoff R
    BMC Immunol; 2021 Sep; 22(1):62. PubMed ID: 34517836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic dissection of immunity to mycobacteria: the human model.
    Casanova JL; Abel L
    Annu Rev Immunol; 2002; 20():581-620. PubMed ID: 11861613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mendelian susceptibility to mycobacterial diseases: State of the puzzle.
    Errami A; Bousfiha AA
    Qatar Med J; 2023; 2023(2):25. PubMed ID: 38025345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited human IFN-γ deficiency underlies mycobacterial disease.
    Kerner G; Rosain J; Guérin A; Al-Khabaz A; Oleaga-Quintas C; Rapaport F; Massaad MJ; Ding JY; Khan T; Ali FA; Rahman M; Deswarte C; Martinez-Barricarte R; Geha RS; Jeanne-Julien V; Garcia D; Chi CY; Yang R; Roynard M; Fleckenstein B; Rozenberg F; Boisson-Dupuis S; Ku CL; Seeleuthner Y; Béziat V; Marr N; Abel L; Al-Herz W; Casanova JL; Bustamante J
    J Clin Invest; 2020 Jun; 130(6):3158-3171. PubMed ID: 32163377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic determinants of susceptibility to Mycobacterial infections: IRF8, a new kid on the block.
    Salem S; Gros P
    Adv Exp Med Biol; 2013; 783():45-80. PubMed ID: 23468103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mendelian susceptibility to mycobacterial disease: 2014-2018 update.
    Rosain J; Kong XF; Martinez-Barricarte R; Oleaga-Quintas C; Ramirez-Alejo N; Markle J; Okada S; Boisson-Dupuis S; Casanova JL; Bustamante J
    Immunol Cell Biol; 2019 Apr; 97(4):360-367. PubMed ID: 30264912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Child with Recurrent Mycobacterial Disease.
    Reed B; Dolen WK
    Curr Allergy Asthma Rep; 2018 Jun; 18(8):44. PubMed ID: 29936646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.